Pembrolizumab (pembro) monotherapy for previously untreated advanced hepatocellular carcinoma (HCC): Phase II KEYNOTE-224 study. This is an ASCO Meeting Abstract from the 2021 Gastrointestinal Cancers ...
Multicentre retrospective assessment of toxicity and response to immunotherapy in elderly patients with metastatic melanoma. Number (%) of pts with clinically meaningful improvement or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results